Showing results (151-160 of 182) with videos related to
Sort By:
Pageof 19
ACS Pharmacology & Translational Science|December 17, 2020
Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19Giovanni Bocci, Steven B Bradfute, Chunyan Ye, et al.Plos One|November 13, 2015
Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPasesTudor I Oprea, Larry A Sklar, Jacob O Agola, et al.Analytical Chemistry|January 22, 2013
Elastomeric negative acoustic contrast particles for affinity capture assaysKevin W Cushing, Menake E Piyasena, Nick J Carroll, et al.Journal of Biomolecular Screening|August 28, 2012
A selective ATP-binding cassette subfamily G member 2 efflux inhibitor revealed via high-throughput flow cytometryJ Jacob Strouse, Irena Ivnitski-Steele, Hadya M Khawaja, et al.The Journal of Steroid Biochemistry and Molecular Biology|July 26, 2011
Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivityMegan K Dennis, Angela S Field, Ritwik Burai, et al.ACS Chemical Biology|April 11, 2012
A competitive nucleotide binding inhibitor: in vitro characterization of Rab7 GTPase inhibitionJacob O Agola, Lin Hong, Zurab Surviladze, et al.Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
High-Throughput Flow Cytometry Screening of Multidrug Efflux SystemsMark K Haynes, Matthew Garcia, Ryan Peters, et al.ACS Chemical Biology|August 14, 2012
Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractilityDavid M Thal, Kristoff T Homan, Jun Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer PatientsYuna Guo, S Ray Kenney, Linda Cook, et al.FASEB Bioadvances|May 12, 2021
Inhibition of the HEG1-KRIT1 interaction increases KLF4 and KLF2 expression in endothelial cellsMiguel Alejandro Lopez-Ramirez, Sara McCurdy, Wenqing Li, et al.Pageof 19